生物学的製剤の世界市場:タンパク質治療薬、ワクチン、細胞治療薬...市場調査レポートについてご紹介

【英文タイトル】Global Biologic Therapeutics Market 2014-2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Molecule Type
08. Geographical Segmentation
09. Buying Criteria
10. Global Protein Therapeutics Market
10.1 Introduction
10.2 Drivers, Challenges and Trends
10.3 Market Size and Forecast
10.4 Market Segmentation by Molecule Type
10.4.1 Global Monoclonal Antibodies Market
10.4.2 Global Enzymes Market
10.4.3 Global Other Protein Therapeutics Market
11. Global Vaccines Market
11.1 Introduction
11.2 Drivers, Challenges and Trends
11.3 Market Size and Forecast
11.4 Market Segmentation by Composition
11.5 Market Segmentation by End-user Age Group
11.5.1 Global Pediatric Vaccines Market
11.5.2 Global Adult Vaccines Market
12. Global Cell Therapy Market
12.1 Introduction
12.2 Drivers, Challenges and Trends
12.3 Market Size and Forecast
13. Market Growth Drivers
13.1.1 Overall Market Drivers
13.1.2 Segment Specific Drivers
14. Drivers and their Impact
15. Market Challenges
15.1.1 Overall Market Challenges
15.1.2 Segment Specific Challenges
16. Impact of Drivers and Challenges
17. Market Trends
17.1.1 Overall Market Trends
17.1.2 Segment Specific Trends
18. Trends and their Impact
19. Competitive Scenario
19.1 Key News
19.2 Mergers and Acquisitions
20. Market Share Analysis 2013
20.1 Market Snapshot of Top Vendors
20.2 Market Share of Key Vendors
20.3 Market Forecast of Key Vendors
20.3.1 F. Hoffmann-La Roche
20.3.2 Sanofi
20.3.3 Amgen
20.3.4 Novo Nordisk
21. Market Assessment of Major Biologic Therapeutics of Key Vendors
21.1 F. Hoffmann-La Roche
21.1.1 Avastin
21.1.2 Herceptin
21.1.3 Kadcyla
21.1.4 Lucentis
21.1.5 MabThera/Rituxan
21.1.6 Pegasys
21.1.7 Perjeta
21.2 Sanofi
21.2.1 Aldurazyme
21.2.2 Cerezyme
21.2.3 Fabrazyme
21.2.4 Myozyme/Lumizyme
21.2.5 Lantus
21.3 Amgen
21.3.1 Enbrel
21.3.2 Neulasta
21.3.3 Xgeva/Prolia
21.4 Novo Nordisk
21.4.1 NovoRapid/NovoLog
21.4.2 Victoza
21.5 Other Prominent and Future Vendors
22. Key Vendor Analysis
22.1 Amgen
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Product Segmentation by Revenue 2013
22.1.4 Sales by Geographical Segmentation 2013
22.1.5 Business Strategy
22.1.6 Key Information
22.1.7 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Geographical Segmentation by Revenue
22.2.6 Business Strategy
22.2.7 Key Information
22.2.8 SWOT Analysis
22.3 Novo Nordisk A/S
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Strategy
22.3.5 Revenue Segmentation by Business
22.3.6 Revenue Comparison by Business Segments 2012 and 2013
22.3.7 Sales by Geography
22.3.8 Key Information
22.3.9 SWOT Analysis
22.4 Sanofi
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Geographical Segmentation by Revenue 2013
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
23. Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Biologic Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Biologic Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Biologic Therapeutics Market by Molecule Type 2013
Exhibit 5: Global Biologic Therapeutics Market by Molecule Type 2018
Exhibit 6: Global Biologic Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 7: Global Biologic Therapeutics Market by Molecule Type 2013-2018
Exhibit 8: Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 9: YoY Growth Rate of Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 10: Global Biologic Therapeutics Market Segmentation by Geography 2013
Exhibit 11: Key Factors Influencing the Global Protein Therapeutics Market
Exhibit 12: Global Protein Therapeutics Market Key Trends
Exhibit 13: Global Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 14: Global Protein Therapeutics Market by Molecule Type
Exhibit 15: Global Protein Therapeutics Market by Molecule Type 2013
Exhibit 16: Global Protein Therapeutics Market by Molecule Type 2018
Exhibit 17: Global Protein Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 18: Global Protein Therapeutics Market by Molecule Type 2013-2018
Exhibit 19: Global Protein Therapeutics Market Segmentation 2013-2018
Exhibit 20: YoY Growth Rate of Global Protein Therapeutics Market Segments 2013-2018
Exhibit 21: Global Monoclonal Antibodies Market 2013-2018 (US$ billion)
Exhibit 22: Global Enzymes Market 2013-2018 (US$ billion)
Exhibit 23: Global Other Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 24: Global Vaccines Market Drivers
Exhibit 25: Global Vaccines Market Challenges
Exhibit 26: Global Vaccines Market Trends
Exhibit 27: Global Vaccines Market 2013-2018 (US$ billion)
Exhibit 28: Global Vaccines Market Segmentation by Vaccine Type
Exhibit 29: Global Vaccines Market Segmentation by End-user Age Group
Exhibit 30: Global Vaccines Market Segmentation by End-user Age Group 2013
Exhibit 31: Global Vaccines Market Segmentation by End-user Age Group 2018
Exhibit 32: Global Vaccines Market Segmentation by End-user Age Group 2013-2018 (US$ billion)
Exhibit 33: Global Vaccines Market Segmentation by End-user Age Group 2013-2018
Exhibit 34: Global Vaccines Market Segmentation 2013-2018
Exhibit 35: YoY Growth Rate of Global Vaccines Market Segments 2013-2018
Exhibit 36: Global Pediatric Vaccines Market 2013-2018 (US$ billion)
Exhibit 37: Global Adult Vaccines Market 2013-2018 (US$ billion)
Exhibit 38: Key Factors Influencing the Global Cell Therapy Market
Exhibit 39: Global Cell Therapy Market 2013-2018 (US$ billion)
Exhibit 40: Global Biologic Therapeutics Market Drivers
Exhibit 41: Global Biologic Therapeutics Overall Market Drivers
Exhibit 42: World’s Population Aged 60 and Above 2010-2020 (billion)
Exhibit 43: Global Biologic Therapeutics Segment Specific Drivers
Exhibit 44: Incidence and Prevalence of Type 1 Diabetes in Children (0-14 Years) 2013 (in thousands)
Exhibit 45: Global Biologic Therapeutics Market Challenges
Exhibit 46: Global Biologic Therapeutics Overall Market Challenges
Exhibit 47: Global Biologic Therapeutics Segment Specific Challenges
Exhibit 48: Global Biologic Therapeutics Market Trends
Exhibit 49: Global Biologic Therapeutics Market General Trends
Exhibit 50: Global Biologic Therapeutics Segment Specific Trends
Exhibit 51: Market Statistics for Key Vendors in Global Biologic Therapeutics Market
Exhibit 52: Global Biologic Therapeutics Market Share Analysis 2013
Exhibit 53: Global Biologic Therapeutics Market Share Analysis 2018
Exhibit 54: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2013
Exhibit 55: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2018
Exhibit 56: YoY Growth Rate of Key Vendors in the Global Biologic Therapeutics Market
Exhibit 57: F. Hoffmann-La Roche Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 58: Sanofi Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 59: Amgen Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 60: Novo Nordisk Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 61: Revenue of Major Biologic Therapeutics of Key Vendors
Exhibit 62: F. Hoffmann-La Roche: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 63: Geography-wise Segmentation of Avastin 2013 (US$ million)
Exhibit 64: Geography-wise Segmentation of Avastin 2013
Exhibit 65: Avastin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 66: Geography-wise Segmentation of Herceptin 2013 (US$ million)
Exhibit 67: Geography-wise Segmentation of Herceptin 2013
Exhibit 68: Herceptin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 69: Geography-wise Segmentation of Kadcyla 2013 (US$ million)
Exhibit 70: Geography-wise Segmentation of Kadcyla 2013
Exhibit 71: Kadcyla Market Size and Forecast 2013-2018 (US$ million)
Exhibit 72: Timeline of Key Regulatory Approvals of Lucentis
Exhibit 73: Lucentis Sales by Geographical Segmentation 2006-2013 (US$ million)
Exhibit 74: Lucentis Revenue 2006-2013 (US$ million)
Exhibit 75: Geography-wise Segmentation of MabThera/Rituxan 2013 (US$ million)
Exhibit 76: Geography-wise Segmentation of MabThera/Rituxan 2013
Exhibit 77: MabThera/Rituxan Market Size and Forecast 2013-2018 (US$ million)
Exhibit 78: Geography-wise Segmentation of Pegasys 2013 (US$ million)
Exhibit 79: Geography-wise Segmentation of Pegasys 2013
Exhibit 80: Geography-wise Segmentation of Perjeta 2013 (US$ million)
Exhibit 81: Geography-wise Segmentation of Perjeta 2013
Exhibit 82: Perjeta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 83: SanofI: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 84: Geography-wise Segmentation of Aldurazyme 2013 (US$ million)
Exhibit 85: Geography-wise Segmentation of Aldurazyme 2013
Exhibit 86: Geography-wise Segmentation of Cerezyme 2013 (US$ million)
Exhibit 87: Geography-wise Segmentation of Cerezyme 2013
Exhibit 88: Geography-wise Segmentation of Fabrazyme 2013 (US$ million)
Exhibit 89: Geography-wise Segmentation of Fabrazyme 2013
Exhibit 90: Geography-wise Segmentation of Myozyme/Lumizyme 2013 (US$ million)
Exhibit 91: Geography-wise Segmentation of Myozyme/Lumizyme 2013
Exhibit 92: Geography-wise Segmentation of Lantus 2013 (US$ million)
Exhibit 93: Geography-wise Segmentation of Lantus 2013
Exhibit 94: Lantus Market Size and Forecast 2013-2018 (US$ million)
Exhibit 95: Geography-wise Segmentation of Enbrel 2013 (US$ million)
Exhibit 96: Geography-wise Segmentation of Enbrel 2013
Exhibit 97: Enbrel Market Size and Forecast 2013-2018 (US$ million)
Exhibit 98: Geography-wise Segmentation of Neulasta 2013 (US$ million)
Exhibit 99: Geography-wise Segmentation of Neulasta 2013
Exhibit 100: Neulasta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 101: Geography-wise Segmentation of Xgeva/Prolia 2013 (US$ million)
Exhibit 102: Geography-wise Segmentation of Xgeva/Prolia 2013
Exhibit 103: Xgeva/Prolia Market Size and Forecast 2013-2018 (US$ million)
Exhibit 104: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 105: Geography-wise Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 106: Geography-wise Segmentation of NovoRapid/NovoLog 2013 (US$ million)
Exhibit 107: Geography-wise Segmentation of NovoRapid/NovoLog 2013
Exhibit 108: NovoRapid/NovoLog Market Size and Forecast 2013-2018 (US$ million)
Exhibit 109: Geography-wise Segmentation of Victoza 2013 (US$ million)
Exhibit 110: Geography-wise Segmentation of Victoza 2013
Exhibit 111: Victoza Market Size and Forecast 2013-2018 (US$ million)
Exhibit 112: Amgen: Product Segmentation by Revenue 2013
Exhibit 113: Amgen: Sales by Geographical Segmentation 2013
Exhibit 114: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 115: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 116: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 117: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 118: Business Segments of Novo Nordisk A/S 2013
Exhibit 119: Novo Nordisk A/S: Business Segmentation 2013
Exhibit 120: Novo Nordisk A/S: Revenue Comparison 2012 and 2013 (US$ million)
Exhibit 121: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 122: Sanofi: Business Segmentation by Revenue 2013
Exhibit 123: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 124: Sanofi: Geographical Segmentation by Revenue 2013


【レポート販売概要】

■ タイトル:生物学的製剤の世界市場:タンパク質治療薬、ワクチン、細胞治療薬
■ 英文:Global Biologic Therapeutics Market 2014-2018
■ 発行日:2014年10月29日
■ 調査会社:Technavio
■ 商品コード:IRTNTR4486
■ 調査対象地域:グローバル
  • 鉛蓄電池の世界市場予測(~2024年)
    “The global lead acid battery market is projected to grow at a CAGR of about 4 - 5% from 2019 to 2024” The global lead acid battery market is projected to reach USD 52.5 billion by 2024 from an estimated USD 41.6 billion in 2019, at a CAGR of 4.7% during the forecast period. This growth can be attributed to factors such as the basic requirement of cost-effective battery storage solutions in the de …
  • 実験室用カートの世界市場2016-2020
    About Laboratory Cart Laboratory carts fall into the category of laboratory furniture and provide easy transportation of equipment and samples within the laboratory. There are different types of laboratory carts based on the processes involved and the materials that need to be transported. The most commonly transported materials are glassware, equipment, chemicals, books, and instruments. Some of …
  • バイオ・ポリエチレンテレフタレートの世界市場
    The report covers the global bio-polyethylene terephthalate market that is segmented on the basis of application and geography. The global bio-polyethylene terephthalate market was valued at $457.9 million in 2014, and is projected to reach $1,317.5 million by 2019, at a CAGR of 23.5% from 2014 to 2019. The global bio-polyethylene terephthalate market has been analyzed based on the current proceed …
  • C型肝炎治療薬パイプライン分析
    “Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mecha …
  • Roc Oil Company Limited:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Roc Oil Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Roc Oil Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • 神経診断および監視デバイスの米国市場:製品別
    Neurodiagnostic and Monitoring Devices Market in the US: About this market Technavio’s neurodiagnostic and monitoring devices market in the US analysis considers sales ICP monitoring devices, EEG devices, EMG devices, and other products. In 2019, the ICP monitoring devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the g …
  • タリウムの世界市場動向2014/2015
    The report presents a thorough study of thallium, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing thallium worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: thallium production in the country, major manufac …
  • 輸送用燃料電池の市場分析:Analyzing Transportation Fuel Cells
    The advent of gasoline-based transportation and the rapid progression of an industry across the globe which has kept on coming up with thousands of models and vehicle variants but not serious looked at an alternative fuel till yet has brought about industry wide concern and the realignment of time and resources to achieving the objective of a cleaner efficient and environmentally compliant fuel. A …
  • Hcl-rhFVIII (Hemophilia A and B):市場予測と分析(~2022)
    Hcl-rhFVIII (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing thr …
  • セルフモニタリング血糖検査用ストリップの世界市場2017-2021
    About Self-Monitoring Blood Glucose StripsThe blood glucose strips market is a part of the SMBG market. The global SMBG devices market is organized and is expected to grow rapidly with the increase in incidence of diabetes across the globe. Vendors are offering SMBG devices that are safe, portable, accurate, and require low power consumption. The availability of innovative and advanced SMBG device …
  • Malaria:医療検査市場2014
    The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commerci …
  • 自動車用慣性計測装置(IMU)センサーの世界市場2018-2022
    About Automotive Inertial Measurement Unit (IMU) Sensors The inertial measurement unit (IMU) is an electronic device, which is used to measure the non-gravitational force per unit mass, angular velocity, and the changes in the magnetic field surrounding the vehicle or specific parts of the vehicle. An IMU is a fusion sensor unit, which consists of accelerometers and gyroscopes. Technavio’s analyst …
  • 航空機用ベアリングの世界市場予測(~2022年):ころ軸受、玉軸受
    The aerospace bearings market is projected to grow from USD 7.88 Billion in 2016 to USD 11.19 Billion by 2022, at a CAGR of 6.01% during the forecast period. Factors such as increase in aircraft orders and deliveries across the globe, and upgradation of aircraft to reduce operational cost are the major growth factors for the aerospace bearings market. The market has been segmented on the basis of …
  • セルフバランススクーターの世界市場2016-2020
    About the Self-Balancing Scooter Market Self-balancing scooters are two-wheeled boards with motors that can be used for commuting. They look similar to the popular self-balancing electric vehicle, called the Segway, but they come without a handle. The self-balancing scooter works on gyroscopic technology and can travel at an average speed 15 km/h. It contains lithium-ion batteries that can be char …
  • グリーンパッケージング(再利用・再生可能包装材料)の世界市場
    About Green Packaging Green packaging is produced from sustainable, renewable, and recyclable raw materials. Green packaging technology uses materials such as paper, plastic, metal, and glass, which can be easily bent or molded as needed. One of the major advantages of green packaging is that it produces fewer toxic emissions. With increased environmental concerns worldwide and the need to reduce …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。